BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakach E, O'Regan R, Meisel J, Li X. Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies. Clin Breast Cancer 2021:S1526-8209(21)00261-5. [PMID: 34629314 DOI: 10.1016/j.clbc.2021.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Mao C, Zhan Y, Zhao Y, Chen Y, Lin Y. Albumin-Coated Framework Nucleic Acids as Bionic Delivery System for Triple-Negative Breast Cancer Therapy. ACS Appl Mater Interfaces 2022. [PMID: 36001395 DOI: 10.1021/acsami.2c10612] [Reference Citation Analysis]
2 Crabtree JS, Miele L. Precision diagnostics in cancer: Predict, prevent, and personalize. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.03.005] [Reference Citation Analysis]